Variables influencing tumor dosimetry in radioimmunotherapy of CEA-expressing cancers with anti-CEA and antimucin monoclonal antibodies. [electronic resource]
Producer: 19970409Description: 409-18 p. digitalISSN:- 0161-5505
- Adenocarcinoma -- metabolism
- Aged
- Antibodies, Monoclonal -- pharmacokinetics
- Carcinoembryonic Antigen -- analysis
- Colorectal Neoplasms -- metabolism
- Female
- Half-Life
- Humans
- Iodine Radioisotopes -- therapeutic use
- Male
- Manganese -- therapeutic use
- Middle Aged
- Mucins -- metabolism
- Neptunium -- therapeutic use
- Ovarian Neoplasms -- metabolism
- Radioimmunotherapy
- Radioisotopes -- therapeutic use
- Radiotherapy Dosage
- Thyroid Neoplasms -- metabolism
- Tissue Distribution
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.